PL1781375T3 - Mieszanina polifenoli do zapobiegania wystąpienia raka gruczołu krokowego u osoby, u której rozpoznano neoplazję śródnabłonkową gruczołu krokowego wysokiego stopnia (HGPIN) - Google Patents

Mieszanina polifenoli do zapobiegania wystąpienia raka gruczołu krokowego u osoby, u której rozpoznano neoplazję śródnabłonkową gruczołu krokowego wysokiego stopnia (HGPIN)

Info

Publication number
PL1781375T3
PL1781375T3 PL05768182T PL05768182T PL1781375T3 PL 1781375 T3 PL1781375 T3 PL 1781375T3 PL 05768182 T PL05768182 T PL 05768182T PL 05768182 T PL05768182 T PL 05768182T PL 1781375 T3 PL1781375 T3 PL 1781375T3
Authority
PL
Poland
Prior art keywords
hgpin
polyphenols
onset
prevention
mixture
Prior art date
Application number
PL05768182T
Other languages
English (en)
Inventor
Saverio Bettuzzi
Arnaldo Corti
Sergio Corvetta
Original Assignee
Genprofiler S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITBZ20040037 external-priority patent/ITBZ20040037A1/it
Priority claimed from ITBZ20050004 external-priority patent/ITBZ20050004A1/it
Application filed by Genprofiler S R L filed Critical Genprofiler S R L
Publication of PL1781375T3 publication Critical patent/PL1781375T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
PL05768182T 2004-07-27 2005-07-21 Mieszanina polifenoli do zapobiegania wystąpienia raka gruczołu krokowego u osoby, u której rozpoznano neoplazję śródnabłonkową gruczołu krokowego wysokiego stopnia (HGPIN) PL1781375T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITBZ20040037 ITBZ20040037A1 (it) 2004-07-27 2004-07-27 Miscela di catechine ovvero polifenoli estratti dal te' verde cinese o da altri vegetali con efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico.
ITBZ20050004 ITBZ20050004A1 (it) 2005-02-16 2005-02-16 Miscela di catechine ovvero polifenoli estratti dal Te' Verde cinese (o da altri vegetali) Efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico e per il trattamento efficace della sintomatologia dell'ipertrofia prostati
EP05768182.7A EP1781375B1 (en) 2004-07-27 2005-07-21 Mixture of polyphenols for the prevention of the onset of prostate cancer in a person diagnosed with High Grade Prostate Intraepithelial Neoplasia (HGPIN)
PCT/IB2005/002107 WO2006013420A2 (en) 2004-07-27 2005-07-21 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph)

Publications (1)

Publication Number Publication Date
PL1781375T3 true PL1781375T3 (pl) 2013-11-29

Family

ID=35447932

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05768182T PL1781375T3 (pl) 2004-07-27 2005-07-21 Mieszanina polifenoli do zapobiegania wystąpienia raka gruczołu krokowego u osoby, u której rozpoznano neoplazję śródnabłonkową gruczołu krokowego wysokiego stopnia (HGPIN)

Country Status (7)

Country Link
US (1) US8044095B2 (pl)
EP (1) EP1781375B1 (pl)
JP (2) JP2008508252A (pl)
CA (1) CA2612149C (pl)
ES (1) ES2427170T3 (pl)
PL (1) PL1781375T3 (pl)
WO (1) WO2006013420A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2214688B1 (en) 2007-10-26 2018-09-05 Csir Management and treatment of benign prostatic hyperplasia
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
WO2010046238A1 (en) * 2008-10-20 2010-04-29 Unilever Nv An antimicrobial composition
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
IN2014MN00808A (pl) 2011-11-03 2015-09-04 Unilever Plc
WO2013075920A2 (en) * 2011-11-25 2013-05-30 Unilever N.V. An oral care composition
WO2013081046A1 (ja) * 2011-11-29 2013-06-06 国立大学法人信州大学 ブドウ梗由来抽出物
CN102754832A (zh) * 2012-07-12 2012-10-31 赵四海 用酚和醌融解肿瘤和改造癌细胞的治病方法
JP6279591B2 (ja) * 2012-10-15 2018-02-14 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 健康を促進するための緑茶抽出物と紅茶抽出物との混合物
KR101492713B1 (ko) * 2013-05-06 2015-02-12 대구한의대학교산학협력단 미숙 떫은 감의 분획물을 이용한 전립선 비대증 예방 또는 치료용 조성물
JP7303558B2 (ja) * 2017-10-19 2023-07-05 イェール ユニバーシティー 薬草の抽出物によるアンドロゲン受容体の阻害、及び該抽出物の組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266977A (en) * 1991-07-12 1993-11-30 Linden Harry A Lens device and method
US5585871A (en) * 1995-05-26 1996-12-17 Linden; Harry Multi-function display apparatus
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
DE19842858A1 (de) 1998-09-18 2000-03-30 Vollbrecht H Ruediger Entkoffeinierung von Tee
KR100319973B1 (ko) 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
WO2000057875A1 (en) * 1999-03-30 2000-10-05 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6431705B1 (en) * 1999-11-10 2002-08-13 Infoeye Eyewear heart rate monitor
WO2002067965A1 (en) 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
AU2002254007B2 (en) * 2001-02-22 2006-09-21 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer

Also Published As

Publication number Publication date
CA2612149A1 (en) 2006-02-09
US20080194675A1 (en) 2008-08-14
WO2006013420A3 (en) 2006-04-20
CA2612149C (en) 2015-11-10
JP2012236834A (ja) 2012-12-06
WO2006013420A2 (en) 2006-02-09
EP1781375B1 (en) 2013-06-19
EP1781375A2 (en) 2007-05-09
WO2006013420B1 (en) 2006-06-08
US8044095B2 (en) 2011-10-25
ES2427170T3 (es) 2013-10-29
JP2008508252A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
PL1781375T3 (pl) Mieszanina polifenoli do zapobiegania wystąpienia raka gruczołu krokowego u osoby, u której rozpoznano neoplazję śródnabłonkową gruczołu krokowego wysokiego stopnia (HGPIN)
IL267487A (en) Fraud Risk Advisor
EP1718145A4 (en) CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS
GB2431693B (en) High security padlock construction
EP1805188A4 (en) COMPLEXES OF LUMINESCENT LANTHANIDES
HK1102544A1 (en) Use of herbal compositions in the manufacture of medicine for treating prostate cancer
EP1964043A4 (en) SECURITY TOKENS WITH DISPLAYABLE CLAIMS
EP1917205A4 (en) LOCK DISTRIBUTOR
PL1829874T3 (pl) Tricykliczny związek i jego zastosowanie
EP1713474A4 (en) INDIRUBINE DERIVATIVES WITH ANTICANCER PROPERTIES AGAINST CANCER CELLS IN HUMANS
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
EP1756166A4 (en) DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
EP1809266A4 (en) COMPOUNDS AND PROCEDURES AGAINST CANCER
ZA200702093B (en) Arene ruthenium (II) compounds and their use in cancer therapy
HK1105288A1 (en) Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
AU2003220022A8 (en) Compositions and methods for preventing sporadic neoplasia in colon
ZA200702255B (en) Biotinylated hexadecasaccharides, preparation and use thereof
ZA200701578B (en) Combination anticancer therapy and pharmaceutical compositions therefore
EP1889622A4 (en) SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
GB0401876D0 (en) New use for cancer antigen
EP1813288A4 (en) MEDICAL COMPOSITION, MEDICAL PREPARATION AND COMBINATION PREPARATION
EP2027871A4 (en) NEW CATHEPSIN PREPARATION AGAINST CANCER AND THIS USING CANCER FOR COMBINATION THERAPY AGAINST CANCER
GB2423981B (en) Dispensing means and valve means for use therewith
GB0418062D0 (en) Triple function repositionable water warning device
GB0813636D0 (en) Improved plug divisional